Search references for SARCOPENIC OBESITY. Phrases containing SARCOPENIC OBESITY
See searches and references containing SARCOPENIC OBESITY!SARCOPENIC OBESITY
Medical condition: obesity and loss of muscle
Sarcopenic obesity is a combination of two disease states, sarcopenia and obesity. Sarcopenia is the muscle mass/strength/physical function loss associated
Sarcopenic_obesity
Indian medical doctor
of sarcopenia and sarcopenic obesity in older adults. Kalra has developed several clinically applicable concepts that simplify obesity management, including
Sanjay_Kalra
Metabolically obese normal weight
metabolic profile for those listed as MONW. Abdominal obesity Body composition TOFI Sarcopenic obesity Waist-to-height ratio De Lorenzo, Antonino; Gualtieri
Normal_weight_obesity
Early onset muscle loss due to ageing or immobility
non-contractile material in the skeletal muscle and contribute to sarcopenic muscle. In sarcopenic muscle the distribution of the types of muscle fibers changes
Sarcopenia
Method for estimating body composition
MH, Lyons RF, Elashoff RM (September 1996). "Clinical detection of sarcopenic obesity by bioelectrical impedance analysis". The American Journal of Clinical
Bioelectrical impedance analysis
Bioelectrical_impedance_analysis
Chemical compound
"Exogenous ketone esters as a potential therapeutic for treatment of sarcopenic obesity". American Journal of Physiology. Cell Physiology. 327 (1): C140–C150
1,3-Butanediol
Investigational selective androgen receptor modulator
2b study of enobosarm at doses of 3 to 6 mg/day for this purpose in sarcopenic obese or overweight elderly individuals receiving GLP-1 receptor agonists
Enobosarm
Medical procedure for purifying blood
adults, as they are influenced by inflammation, fluid shifts and sarcopenic obesity. Morphofunctional tools such as muscle ultrasound, multifrequency
Hemodialysis
Chemical compound
β-Hydroxy-β-Methylbutyrate as a New Strategy for the Management of Sarcopenia and Sarcopenic Obesity". Drugs & Aging. 34 (11): 833–840. doi:10.1007/s40266-017-0496-0.
Β-Hydroxy β-methylbutyric acid
Β-Hydroxy_β-methylbutyric_acid
Abnormal kidney structure or gradual loss of kidney function
is not appropriate for people who are metabolically unstable, frail, sarcopenic, or undernourished, and is not recommended for children due to growth
Chronic_kidney_disease
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY
SARCOPENIC OBESITY